Hill-Rom Holdings Inc (NYSE:HRC) updated its first quarter earnings guidance on Friday. The company provided EPS guidance of $0.77-0.79 for the period, compared to the Thomson Reuters consensus EPS estimate of $0.89. The company issued revenue guidance of +3% y/y (Approx $656 million), compared to the consensus revenue estimate of $689.45 million.Hill-Rom Holdings also updated its FY18 guidance to $4.22-4.30 EPS.

A number of research analysts recently commented on the company. Zacks Investment Research upgraded Hill-Rom Holdings from a hold rating to a buy rating and set a $90.00 target price for the company in a research note on Friday, October 27th. KeyCorp restated a buy rating and issued a $82.00 target price on shares of Hill-Rom Holdings in a research note on Tuesday, October 17th. BidaskClub upgraded Hill-Rom Holdings from a sell rating to a hold rating in a research note on Sunday, August 6th. Stifel Nicolaus restated a buy rating and issued a $84.00 target price on shares of Hill-Rom Holdings in a research note on Sunday, July 30th. Finally, Cantor Fitzgerald set a $86.00 price objective on Hill-Rom Holdings and gave the stock a hold rating in a research note on Friday, July 28th. Two equities research analysts have rated the stock with a hold rating and seven have issued a buy rating to the stock. The company has an average rating of Buy and a consensus target price of $87.29.

Hill-Rom Holdings (NYSE:HRC) last released its earnings results on Friday, November 3rd. The medical technology company reported $1.32 earnings per share for the quarter, beating analysts’ consensus estimates of $1.28 by $0.04. The firm had revenue of $738.30 million during the quarter, compared to the consensus estimate of $731.10 million. Hill-Rom Holdings had a return on equity of 19.99% and a net margin of 4.27%. The company’s revenue was up 4.6% compared to the same quarter last year. During the same period in the prior year, the company posted $1.18 EPS.

In other news, SVP Andreas G. Frank sold 3,940 shares of the company’s stock in a transaction on Wednesday, September 13th. The stock was sold at an average price of $77.84, for a total transaction of $306,689.60. Following the completion of the sale, the senior vice president now directly owns 16,701 shares in the company, valued at approximately $1,300,005.84. The transaction was disclosed in a filing with the SEC, which is accessible through this hyperlink. Also, SVP Andreas G. Frank sold 6,870 shares of the company’s stock in a transaction on Thursday, September 14th. The shares were sold at an average price of $77.48, for a total value of $532,287.60. Following the sale, the senior vice president now owns 16,701 shares of the company’s stock, valued at $1,293,993.48. The disclosure for this sale can be found here. Corporate insiders own 2.20% of the company’s stock.

TRADEMARK VIOLATION NOTICE: “Hill-Rom Holdings Inc (HRC) Issues Q1 Earnings Guidance” was originally published by American Banking News and is the property of of American Banking News. If you are reading this piece on another website, it was illegally stolen and republished in violation of US & international copyright & trademark laws. The legal version of this piece can be read at https://www.americanbankingnews.com/2017/11/03/hill-rom-holdings-inc-hrc-issues-q1-earnings-guidance.html.

About Hill-Rom Holdings

Hill-Rom Holdings, Inc is a global medical technology company. The Company operates through four segments: North America Patient Support Systems, International Patient Support Systems, Front Line Care and Surgical Solutions. The Company’s products and services include Patient Support Systems, Front Line Care and Surgical Solutions.

Earnings History and Estimates for Hill-Rom Holdings (NYSE:HRC)

Receive News & Ratings for Hill-Rom Holdings Inc Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Hill-Rom Holdings Inc and related companies with MarketBeat.com's FREE daily email newsletter.